2023 WGND Annual Meeting - Hybrid

November 14, 2023 | Paris, France

Overview

The Stop TB Partnership Working Group on New Drugs’ Annual Meeting has proven valuable as a neutral forum to bring together those working in research and development to get a full understanding of the progress, challenges, and critical issues to developing TB treatment.

Speakers
Melvin Spigelman
TB Alliance, WGND
Dick Chaisson
SMART4TB
Michel Pieren
BioVersys
Katya Kurbatova
US CDC TBTC
Simbarashe Takuva
Otsuka
Lorenzo Guglielmetti
MSF
Maria Beaumont
TB Alliance
David Holtzman
Gates Medical Research Institute
Robert Bates
GlaxoSmithKline
Vidya Mave
AIDS Clinical Trials Group
Meeting Recap

The Working Group on New TB Drugs, in collaboration with the New Diagnostics Working Group, Working Group on New Vaccines, FIND, IAVI, and TB Alliance, co-hosted the New Tools Summit at the Marriot Champs Elysée Hotel in Paris, France on Tuesday, 14 November 2023. The WGND Annual Meeting was a hybrid style meeting with both 170+ in-person attendees and 100+ virtual participants. 

A recording of the meeting is available here: https://vimeo.com/895293066?share=copy#t=0

  • TB Drug Developer, Consortium, & Trial Presentations
    SMART4TB
    Dick Chaisson
    https://www.newtbdrugs.org/sites/default/files/meetings/files/01_Dick%20Chaisson_SMART4TB.pdf
    BioVersys
    Michel Pieren
    https://www.newtbdrugs.org/sites/default/files/meetings/files/02_Michel%20Pieren_BioVersys_updated.pdf
    US CDC TB Trials Consortium
    Katya Kurbatova
    https://www.newtbdrugs.org/sites/default/files/meetings/files/03_Katya%20Kurbatova_TBTC.pdf
    Otsuka
    Simbarashe Takuva
    https://www.newtbdrugs.org/sites/default/files/meetings/files/04_Simba%20Takuva_Otsuka.pdf
    endTB & endTB-Q
    Lorenzo Guglielmetti
    https://www.newtbdrugs.org/sites/default/files/meetings/files/05_Lorenzo%20Guglielmetti_endTB_endTBQ.pdf
    TB Alliance
    Maria Beaumont
    https://www.newtbdrugs.org/sites/default/files/meetings/files/06_Maria%20Beaumont_TB%20Alliance.pdf
    Gates Medical Research Institute
    David Holtzman
    https://www.newtbdrugs.org/sites/default/files/meetings/files/07_David%20Holtzman_Gates%20Medical%20Research%20Institute.pdf
    GlaxoSmithKline
    Robert Bates
    https://www.newtbdrugs.org/sites/default/files/meetings/files/08_Robert%20Bates_GSK.pdf
    AIDS Clinical Trials Group
    Vidya Mave
    https://www.newtbdrugs.org/sites/default/files/meetings/files/09_Vidya%20Mave_ACTG_updated.pdf